Comparative cardiovascular effectiveness and safety of SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors according to frailty in type 2 diabetes

A Kutz, DH Kim, DJ Wexler, J Liu… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE To evaluate the comparative cardiovascular effectiveness and safety of sodium–
glucose cotransporter 2 inhibitors (SGLT-2is), glucagon-like peptide 1 receptor agonists …

[PDF][PDF] Vital signs: improving antibiotic use among hospitalized patients

MD Scott Fridkin, J Baggs, SM MD, PM MD… - Morbidity and mortality …, 2014 - cdc.gov
Background: Antibiotics are essential to effectively treat many hospitalized patients.
However, when antibiotics are prescribed incorrectly, they offer little benefit to patients and …

Comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass: the National Patient-Centered Clinical Research Network (PCORNet) Bariatric …

KM McTigue, R Wellman, E Nauman, J Anau… - JAMA …, 2020 - jamanetwork.com
Importance Bariatric surgery can lead to substantial improvements in type 2 diabetes
(T2DM), but outcomes vary across procedures and populations. It is unclear which bariatric …

Graphical depiction of longitudinal study designs in health care databases

S Schneeweiss, JA Rassen, JS Brown… - Annals of internal …, 2019 - acpjournals.org
Pharmacoepidemiologic and pharmacoeconomic analysis of health care databases has
become a vital source of evidence to support health care decision making and efficient …

Empagliflozin and the risk of heart failure hospitalization in routine clinical care: a first analysis from the EMPRISE study

E Patorno, A Pawar, JM Franklin, M Najafzadeh… - Circulation, 2019 - Am Heart Assoc
Background: The EMPA-REG OUTCOME trial (Empagliflozin Cardiovascular Outcome Event
Trial in Type 2 diabetes Mellitus Patients) showed that empagliflozin, a sodium-glucose …

Tofacitinib and risk of malignancy: results from the safety of tofacitinib in routine care patients with rheumatoid arthritis (STAR‐RA) study

F Khosrow‐Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - Wiley Online Library
Objectives Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …

Prognostic indices for older adults: a systematic review

LC Yourman, SJ Lee, MA Schonberg, EW Widera… - Jama, 2012 - jamanetwork.com
Context To better target services to those who may benefit, many guidelines recommend
incorporating life expectancy into clinical decisions. Objective To assess the quality and …

Many Medicare beneficiaries do not fill high-price specialty drug prescriptions

SB Dusetzina, HA Huskamp, RL Rothman… - Health …, 2022 - healthaffairs.org
For high-price drugs, Medicare Part D beneficiaries who do not receive a low-income
subsidy must pay a percentage of the drug's price for each medication fill. Without that …

Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012

J Baggs, SK Fridkin, LA Pollack… - JAMA internal …, 2016 - jamanetwork.com
Importance The rising threat of antibiotic resistance and other adverse consequences
resulting from the misuse of antibiotics requires a better understanding of antibiotic use in …

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

A Pawar, RJ Desai, DH Solomon, AJS Ortiz… - Annals of the …, 2019 - ard.bmj.com
Objective To investigate the rate of serious bacterial, viral or opportunistic infection in
patients with rheumatoid arthritis (RA) starting tocilizumab (TCZ) versus tumour necrosis …